tenidap has been researched along with Chronic Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hao, Y; Hong, Z; Wu, X; Xu, L; Yu, P; Zhu, G | 1 |
| Egido, J; Hernández, P; Herrero-Beaumont, G; López-Armada, MJ; Martínez, J; Navarro, F; Palacios, I; Sánchez-Pernaute, O | 1 |
2 other study(ies) available for tenidap and Chronic Disease
| Article | Year |
|---|---|
Tenidap, an agonist of the inwardly rectifying K+ channel Kir2.3, delays the onset of cortical epileptiform activity in a model of chronic temporal lobe epilepsy.
Topics: Animals; Chronic Disease; Disease Models, Animal; Down-Regulation; Epilepsy, Temporal Lobe; Female; Hippocampus; Indoles; Oxindoles; Potassium Channels, Inwardly Rectifying; Rats; Rats, Wistar; Time Factors | 2013 |
Antifibroproliferative effect of tenidap in chronic antigen-induced arthritis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experimental; Cell Division; Cells, Cultured; Chronic Disease; Collagen; Diclofenac; DNA Primers; Dose-Response Relationship, Drug; Down-Regulation; Extracellular Matrix; Fibronectins; Hyperplasia; Indoles; Oxindoles; Rabbits; RNA, Messenger; Synovial Membrane; Transforming Growth Factor beta | 1997 |